Literature DB >> 31199235

Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma.

Ross J Mason1, Lori Wood2, Anil Kapoor3, Naveen Basappa4, George Bjarnason5, Stephen A Boorjian6, Rodney H Breau7, Ilias Cagiannos7, Michael A S Jewett8, Pierre I Karakiewicz9, Wassim Kassouf10, Christian Kollmannsberger11, Aly-Khan A Lalani12, Jean-Baptiste Lattouf9, Luke T Lavallée7, Stephen Pautler13, Nicholas Power13, Patrick Richard14, Alan So15, Simon Tanguay10, Ricardo A Rendon1.   

Abstract

Entities:  

Year:  2019        PMID： 31199235      PMCID： PMC6570591          DOI： 10.5489/cuaj.5786

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  65 in total

1.  Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

Authors:  R C Flanigan; S E Salmon; B A Blumenstein; S I Bearman; V Roy; P C McGrath; J R Caton; N Munshi; E D Crawford
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

2.  Laparoscopic cytoreductive nephrectomy: the M. D. Anderson Cancer Center experience.

Authors:  Surena F Matin; Lydia T Madsen; Christopher G Wood
Journal:  Urology       Date:  2006-09-18       Impact factor: 2.649

3.  Neoadjuvant (presurgical) therapy for renal cell carcinoma: a new treatment paradigm for locally advanced and metastatic disease.

Authors:  Christopher G Wood; Vitaly Margulis
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

4.  Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.

Authors:  Manabu Tatokoro; Kazutaka Saito; Yasumasa Iimura; Yasuhisa Fujii; Satoru Kawakami; Kazunori Kihara
Journal:  J Urol       Date:  2008-06-11       Impact factor: 7.450

5.  Laparoscopic versus open cytoreductive nephrectomy in advanced renal-cell carcinoma.

Authors:  Manuel S Eisenberg; Maxwell V Meng; Viraj A Master; Marshall L Stoller; Brian I Rini; Peter R Carroll; Christopher J Kane
Journal:  J Endourol       Date:  2006-07       Impact factor: 2.942

6.  Laparoscopic versus open cytoreductive nephrectomy for metastatic renal cell carcinoma.

Authors:  John C Rabets; Jihad Kaouk; Amr Fergany; Antonio Finelli; Inderbir S Gill; Andrew C Novick
Journal:  Urology       Date:  2004-11       Impact factor: 2.649

7.  Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

Authors:  G H Mickisch; A Garin; H van Poppel; L de Prijck; R Sylvester
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

8.  Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma.

Authors:  Robert J Motzer; Jennifer Bacik; Barbara A Murphy; Paul Russo; Madhu Mazumdar
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

9.  Outcome after cytoreductive nephrectomy for metastatic renal cell carcinoma is predicted by fractional percentage of tumour volume removed.

Authors:  Phillip M Pierorazio; James M McKiernan; Tara R McCann; Supriya Mohile; Daniel Petrylak; Mitchell C Benson
Journal:  BJU Int       Date:  2007-10       Impact factor: 5.588

10.  Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.

Authors:  Wassim Kassouf; Ricardo Sanchez-Ortiz; Pheroze Tamboli; Nizar Tannir; Eric Jonasch; Madhur M Merchant; Surena Matin; David A Swanson; Christopher G Wood
Journal:  J Urol       Date:  2007-09-17       Impact factor: 7.450
View more
  6 in total

Review 1.  Redefining the Role of Surgical Management of Metastatic Renal Cell Carcinoma.

Authors:  Walter R Hsiang; Patrick A Kenney; Michael S Leapman
Journal:  Curr Oncol Rep       Date:  2020-03-13       Impact factor: 5.075

2.  Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019.

Authors:  Sebastien J Hotte; Anil Kapoor; Naveen S Basappa; Georg Bjarnason; Christina Canil; Henry J Conter; Piotr Czaykowski; Jeffrey Graham; Samantha Gray; Daniel Y C Heng; Pierre I Karakiewicz; Christian Kollmannsberger; Aly-Khan A Lalani; Scott A North; François Patenaude; Denis Soulières; Phillippe Violette; Eric Winquist; Lori A Wood; Shaan Dudani; Ranjena Maloni; M Neil Reaume
Journal:  Can Urol Assoc J       Date:  2019-10       Impact factor: 1.862

Review 3.  Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma.

Authors:  Alexandre Ingels; Riccardo Campi; Umberto Capitanio; Daniele Amparore; Riccardo Bertolo; Umberto Carbonara; Selcuk Erdem; Önder Kara; Tobias Klatte; Maximilian C Kriegmair; Michele Marchioni; Maria C Mir; Idir Ouzaïd; Nicola Pavan; Angela Pecoraro; Eduard Roussel; Alexandre de la Taille
Journal:  Nat Rev Urol       Date:  2022-05-11       Impact factor: 16.430

4.  Nomogram to predict risk and prognosis of synchronous lung metastasis in renal cell carcinoma: A large cohort analysis.

Authors:  Zhaoxiang Lu; Cheng Yang; Wei He; Jun Zhou; Rong Xiang
Journal:  Medicine (Baltimore)       Date:  2022-07-08       Impact factor: 1.817

5.  A Simple-To-Use Nomogram for Predicting Early Death in Metastatic Renal Cell Carcinoma: A Population-Based Study.

Authors:  Tao Chen; Xiangpeng Zhan; Junfu Du; Xiaoqiang Liu; Wen Deng; Shuaishuai Zhao; Ming Jiang; Yunqiang Xiong; Xiaohai Zhang; Luyao Chen; Bin Fu
Journal:  Front Surg       Date:  2022-03-22

6.  Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.

Authors:  Wenwen Zheng; Weiwei Zhu; Shengqiang Yu; Kangqi Li; Yuexia Ding; Qingna Wu; Qiling Tang; Quan Zhao; Congxiao Lu; Chenyu Guo
Journal:  BMC Cancer       Date:  2020-11-04       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.